UPH - UpHealth GAAP EPS of -$1.82 revenue of $40.5M
- UpHealth press release ( NYSE: UPH ): Q4 GAAP EPS of -$1.82.
- Revenue of $40.5M (+19.5% Y/Y).
-
We expect 2023 revenues to be in the range of $127 to $135 million. This represents growth of 5% to 12% over pro forma 2022 revenue of $121 million. For comparison purposes, both 2023 estimated revenue and 2022 pro forma revenue include five months of operations for IGI and exclude the Indian operations. In 2023, we expect gross margins to be in the range of 43% to 45% and adjusted EBITDA to be in the range of $7 to $10 million.
For further details see:
UpHealth GAAP EPS of -$1.82, revenue of $40.5M